Global Infectious Disease Diagnostics Market Is Likely To Grow At A CAGR Value Of Around 6.9% By 2028

16-May-2022 | Zion Market Research

The global infectious disease diagnostics market was worth around USD 28152.7 million in 2021 and is estimated to grow to about USD 42013.25052 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.9 percent over the forecast period. The report analyzes the digital remittance market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the digital remittance market.

Infectious disease diagnostics is the technique by which the causative agent of an infectious disease is identified and often characterized. The sample of urine, blood, mucus or other body fluids is analyzed to provide information about the causative organism using various diagnostic procedures and instruments. The growth of the infectious disease diagnosis market is mainly due to the increasing global prevalence of infectious diseases such as COVID-19, Ebola, Swine Flu, etc.; growing awareness for early detection using specific diagnostic tests; progress in funding for research on infectious disease diagnostics; and shift in focus from centralized laboratories to decentralized testing services.

The epidemiological burden of infectious diseases like severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, and Zika has opened the door for their early diagnosis & prevention. Likewise, the current outbreak of the COVID-19 pandemic has enormously augmented the demand for various POC diagnostic kits for early diagnosis and control of the spread of coronavirus.

The global infectious disease diagnostics market is segregated based on product, type of testing, technology, disease type, and end-user. Based on product, the global market is distinguished into Reagents, Kits, and Consumables, Instruments, and Software & Services. Based on type of testing, the global market is segregated into Laboratory Testing, and POC Testing. Based on technology, the global market is bifurcated into Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies. Based on disease type, the global market is distinguished into COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases. Based on end-user, the global market is segregated into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users.

Global Infectious Disease Diagnostics Market

The infectious disease diagnostics market is dominated by North America in 2020 and is expected to dominate the market during the forecast period, while the Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The factors influencing the growth of the Asia Pacific infectious disease diagnostics market are rapid urbanization, increasing investments by healthcare providers towards infrastructure development, the need to manage the growing burden of infectious diseases, and government efforts to improve the accessibility of diagnostic services to enhance the prevention by developing products or platforms required for the diagnosis of infectious diseases.

Key players functioning in the global infectious disease diagnostics market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd(Switzerland), bioMérieux SA (France), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Quidel Corporation(US), Hologic, Inc. (US), Siemens Healthineers AG (Germany), Becton, Dickinson and Company (US), PerkinElmer Inc. (US), QIAGEN (Netherlands), Grifols S.A. (Spain), DiaSorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), Sysmex Corporation (Japan), Ortho Clinical Diagnostics (US), Luminex Corporation (US), Meridian Bioscience (US), Genetic Signatures (Australia), OraSure Technologies (US), Trinity Biotech Plc. (Ireland), Chembio Diagnostic Systems, Inc. (US), Seegene Inc. (South Korea), Co-Diagnostics, Inc. (US), ELITechGroup (France), Epitope Diagnostics, Inc. (US), Trivitron Healthcare (India), Meril Life Sciences Pvt. Ltd. (India), InBios International, Inc. (US), and ABACUS Diagnostica Oy (Finland).

Recent Developments:

  • In March 2021, Roche Diagnostics Launched cobas SARS-CoV-2 Variant Set 1 Test to help screen emerging coronavirus mutations.
  • In February 2021, Thermo Fisher Scientific acquired Mesa Biotech (US) to expand the benefits of molecular diagnostics at the point of care.

Browse the full Infectious Disease Diagnostics Market By Product (Reagents, Kits, and Consumables, Instruments, and Software & Services), By Type of Testing (Laboratory Testing, and POC Testing), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, DNA Sequencing & NGS, DNA Microarrays, and Other Technologies), By Disease Type (COVID-19, HIV, HAIs, Hepatitis, CT/NG, HPV, TB, Influenza, and Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes, and Other End Users), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028. Report at

Global infectious disease diagnostics market is segmented as follows:

By Product

  • Reagents, Kits, and Consumables
  • Instruments
  • Software & Services

By Type of Testing

  • Laboratory Testing
  • POC Testing

By Technology

  • Immunodiagnostics
  • Clinical Microbiology
  • PCR
  • DNA Sequencing & NGS
  • DNA Microarrays
  • Other technologies

By Disease Type

  • COVID-19
  • HIV
  • HAIs
  • Hepatitis
  • CT/NG
  • HPV
  • TB
  • Influenza
  • Other Infectious Diseases

By End-User

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Academic Research Institutes
  • Other End Users

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed